Journals / Klinik Psikofarmakoloji Bülteni / 2003 / Cilt: 13 - Sayı: 3

Effects of electroconvulsive therapy on pituitary hormones in depressed patients

Pages
109–117
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Whether there is a causal relationship between these neuroendocrine responses and the therapeutic effect of ECT is remain uncertain.(

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The exact mechanism of the action of electroconvulsive therapy (ECT) has yet to be established.
📊
Key Findings & Data:Methods: Nineteen depressed inpatients (8 males, 11 females; mean age ± SD= 44.77 ± 10.59 years) were undergone to 7 ECT sessions under general anaesthesia using propofol (1mg/kg).
💡
Conclusion & Impact:Conclusions: Whether there is a causal relationship between these neuroendocrine responses and the therapeutic effect of ECT is remain uncertain.(
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The exact mechanism of the action of electroconvulsive therapy (ECT) has yet to be established. In this study, we aimed to test the hypotheses that ECT may cause acute alterations in pituitary hormones and that these hormonal responses to ECT may change throughout repeated ECT sessions. Methods: Nineteen depressed inpatients (8 males, 11 females; mean age ± SD= 44.77 ± 10.59 years) were undergone to 7 ECT sessions under general anaesthesia using propofol (1mg/kg). During the first and seventh ECTs, blood samples were collected 1 min before (baseline) and 2 min after propofol, immediately after ECT, and 30 and 60 min after ECT for measurements of serum prolactin (PRL), adrenocorticotropin (ACTH), cortisol, growth hormone (GH), follicle-stimulating hormone (FSH), and luteinizing hormone (LH). Results: The results of the study confirmed that ECT had highly selective stimulatory effects on the release of PRL, ACTH and cortisol, but not on GH, FSH and LH. The hormonal responses to ECT did not change throughout ongoing ECT procedures, and did not differ between males and females. Conclusions: Whether there is a causal relationship between these neuroendocrine responses and the therapeutic effect of ECT is remain uncertain.(

🔖

Cite This Article

EŞEL, E., KULA, M., BAŞTÜRK, M., SOFUOĞLU, S., REYHANCAN, M., TURAN, M. T. (2022). Effects of electroconvulsive therapy on pituitary hormones in depressed patients. Klinik Psikofarmakoloji Bülteni, Cilt: 13 - Sayı: 3, 109–117. https://ajindex.com/articles/574485

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. The UK ECT Review Group Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. The Lancet 2003; 361: 799-808 2. Mann JJ Neurobiological correlates of the antidepressant action of electroconvulsive therapy. J ECT 1998; 14: 172-180 3. Swartz CM Neuroendocrine effects of electroconvulsive therapy (ECT). Psychopharmacol Bull 1997; 33: 265-271 4. Motreja S, Subbakrishna DK, Subhash MN, Gangadhar BN, Janakiramaiah N, Parameshwara G Gender but not stimulus parameters influence prolactin response to electroconvulsive therapy. Psychoneuroendocrinology 1997; 22: 337-348 5. Deakin JFW, Ferrier IN, Crow TJ, Johnstone EC, Lawler P Effects of ECT on pituitary hormone release: relationship to seizure, clinical variables and outcome. Br J Psychiatry 1983; 143, 618-624 6. Whalley LJ, Eagles JM, Bowler GMR, Bennie JG, Dick HR, Mcguire RJ, Fink G Selective effects of ECT on hypothalamicpituitary activity. Psychol Med 1987; 17: 319-328 7. Florkowski CM, Crozier IG, Nightingale S, Evans MJ, Ellis MJ, Joyce P, Donald RA Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy. Clin Endocrinol 1996; 44: 163-168 8. Sundblom DM, Heikman P, Naukkarinen H, Fyhrquist F Blood concentrations of vasopressin, neuropeptide FF and prolactin are increased by high-dose right unilateral ECT. Peptides 1999; 20: 319-326 9. Aperia B, Bergman H, Engelbrektson K, Thoren M, Wetterberg L Effects of electroconvulsive therapy on neuropsychological function and circulating levels of ACTH, cortisol, prolactin, and TSH in patients with major depressive illness. Acta Psychiatr Scand 1985; 72: 536-541 10. Esel E, Turan T, Kula M, Reyhancan M, Gonul A, Basturk M, Sofuoglu S Effects of electroconvulsive therapy on hypothalamic-pituitary-thyroid axis activity in depressed patients. Progress Neuro-Psychopharmacol & Biol Psychiatry 2002; 26: 1171-1175 11. Bernardo M, Gaya J, Escobar R, Parellada E, Gonzales Monclus E Hypophyseal response to ECT: a higher and faster vasopressin peak. Biol Psychiatry 1993; 33: 670-672 12. Lisanby SH, Devanand DP, Nobler MS, Prudic J, Expectionally high seizure threshold: ECT device limitations. Convuls Ther 1996; 12: 156-164. 13. Lisanby SH, Devanand DP, Prudic J, Pierson D, Nobler MS, Fitzsimons L, Sackeim HA Prolactin response to electroconvulsive therapy: effects of electrode placement and stimulus dosage. Biol Psychiatry 1998; 43: 14